ambroxol has been researched along with Bronchopulmonary Dysplasia in 5 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized trial in 102 preterm newborns with respiratory distress syndrome (RDS) it has been shown that early Ambroxol treatment (30 mg kg(-1) over the first 5 days) significantly reduces the incidence of RDS-associated complications [bronchopulmonary dysplasia (BPD), intraventricular haemorrhage, post-natal acquired pneumonia]." | 9.09 | Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD). ( Böhme, B; Schmalisch, G; Wauer, RR, 2000) |
| "In a randomized trial in 102 preterm newborns with respiratory distress syndrome (RDS) it has been shown that early Ambroxol treatment (30 mg kg(-1) over the first 5 days) significantly reduces the incidence of RDS-associated complications [bronchopulmonary dysplasia (BPD), intraventricular haemorrhage, post-natal acquired pneumonia]." | 5.09 | Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD). ( Böhme, B; Schmalisch, G; Wauer, RR, 2000) |
| "Bronchopulmonary dysplasia was diagnosed in 25% of the infants in the control group, compared to none diagnosed in the work group." | 1.37 | [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report]. ( Andreeva, A; Hitrova, S; Jekova, N; Marinov, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, H | 1 |
| Liu, J | 1 |
| Liu, T | 1 |
| Wang, Y | 1 |
| Dai, W | 1 |
| Zhang, ZQ | 1 |
| Huang, XM | 1 |
| Lu, H | 1 |
| Marinov, B | 1 |
| Jekova, N | 1 |
| Andreeva, A | 1 |
| Hitrova, S | 1 |
| Schmalisch, G | 1 |
| Wauer, RR | 1 |
| Böhme, B | 1 |
2 reviews available for ambroxol and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Antenatal maternal medication administration in preventing respiratory distress syndrome of premature infants: A network meta-analysis.
Topics: Ambroxol; Betamethasone; Bronchopulmonary Dysplasia; Dexamethasone; Female; Humans; Infant, Newborn; | 2018 |
[Ambroxol for the prevention of respiratory distress syndrome in preterm infants: a meta analysis].
Topics: Ambroxol; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Humans; Infant | 2010 |
1 trial available for ambroxol and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Topics: Ambroxol; Bronchopulmonary Dysplasia; Double-Blind Method; Expectorants; Female; Humans; Infant, New | 2000 |
2 other studies available for ambroxol and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
[Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
Topics: Adult; Ambroxol; Bronchopulmonary Dysplasia; Expectorants; Female; Humans; Infant, Newborn; Pregnanc | 2011 |
Hyaline membrane disease: recent developments.
Topics: Ambroxol; Amniotic Fluid; Bronchopulmonary Dysplasia; Female; Glucocorticoids; Humans; Hyaline Membr | 1983 |